Clinical Trial Update: Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sintilimab in combination with chemotherapy as neoadjuvant treatment for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: The Second Affiliated Hospital of Shandong First Medical University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN